---
layout: post
title: "Revocation of Three Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability"
date: 2026-02-05 18:35:11 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-28496
original_published: 2023-01-03 00:00:00 +0000
significance: 8.00
---

# Revocation of Three Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** January 03, 2023 00:00 UTC
**Document Number:** 2022-28496

## Summary

The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUAs) (the Authorizations) issued to the University of Texas MD Anderson Cancer Center, Molecular Diagnostics Laboratory (MD Anderson) for the MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay, and Visby Medical, Inc. for the Visby Medical COVID-19 and Visby Medical COVID-19 Point of Care Test. FDA revoked these Authorizations under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocations, which include an explanation of the reasons for each revocation, are reprinted in this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/01/03/2022-28496/revocation-of-three-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-detection)
- API: https://www.federalregister.gov/api/v1/documents/2022-28496

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
